In addition, our analysis about genomic alterations and methylation of ATG5 showed the concomitant occurrence of ATG5 mutation and ULK2 mutation and indicated that methylation sites of ATG5 could also serve as prognosis predictors in cervical cancer patients. The gene discussed is ULK2; the disease is cervical cancer.